These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38303536)

  • 1. An Insight into Synthetic Strategies, SAR Study and Anticancer Mechanism of Chalcone Derivatives: Medicinal Chemistry Perspective.
    Karati D; Kumar D
    Curr Drug Res Rev; 2024 Jan; ():. PubMed ID: 38303536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
    Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
    Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives.
    Dhaliwal JS; Moshawih S; Goh KW; Loy MJ; Hossain MS; Hermansyah A; Kotra V; Kifli N; Goh HP; Dhaliwal SKS; Yassin H; Ming LC
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unambiguous Identification of β-Tubulin as the Direct Cellular Target Responsible for the Cytotoxicity of Chalcone by Photoaffinity Labeling.
    Zhou B; Yu X; Zhuang C; Villalta P; Lin Y; Lu J; Xing C
    ChemMedChem; 2016 Jul; 11(13):1436-45. PubMed ID: 27203512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents.
    Yang J; Lv J; Cheng S; Jing T; Meng T; Huo D; Ma X; Wen R
    Anticancer Agents Med Chem; 2023; 23(11):1265-1283. PubMed ID: 36825723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective.
    Kumar V; Dhawan S; Girase PS; Awolade P; Shinde SR; Karpoormath R; Singh P
    Curr Med Chem; 2021 Oct; 28(33):6805-6845. PubMed ID: 33749549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advancement in Bioactive Chalcone Hybrids as Potential Antimicrobial Agents in Medicinal Chemistry.
    Maurya A; Agrawal A
    Mini Rev Med Chem; 2024; 24(2):176-195. PubMed ID: 37497710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.
    WalyEldeen AA; Sabet S; El-Shorbagy HM; Abdelhamid IA; Ibrahim SA
    Chem Biol Interact; 2023 Jan; 369():110297. PubMed ID: 36496109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chalcones: Potential Chemotherapeutic Compounds and Educational Tools for Closing the Loop in STEM.
    Russell AE; Gines BR
    Acc Chem Res; 2023 Jun; 56(11):1256-1262. PubMed ID: 36696370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chalcone Derivatives: Promising Starting Points for Drug Design.
    Gomes MN; Muratov EN; Pereira M; Peixoto JC; Rosseto LP; Cravo PVL; Andrade CH; Neves BJ
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28757583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in biological aspects of chalcones: the odyssey continues.
    Rani A; Anand A; Kumar K; Kumar V
    Expert Opin Drug Discov; 2019 Mar; 14(3):249-288. PubMed ID: 30773996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Tetrahydro-[1,2,4]triazolo[3,4-
    Darwish MIM; Moustafa AM; Youssef AM; Mansour M; Yousef AI; El Omri A; Shawki HH; Mohamed MF; Hassaneen HM; Abdelhamid IA; Oishi H
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chalcones against the hallmarks of cancer: a mini-review.
    de Souza PS; Bibá GCC; Melo EDDN; Muzitano MF
    Nat Prod Res; 2022 Sep; 36(18):4809-4826. PubMed ID: 34865580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances of cytotoxic chalconoids targeting tubulin polymerization: Synthesis and biological activity.
    Mirzaei H; Emami S
    Eur J Med Chem; 2016 Oct; 121():610-639. PubMed ID: 27318983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The design and development of imidazothiazole-chalcone derivatives as potential anticancer drugs.
    Kamal A; Kashi Reddy M; Viswanath A
    Expert Opin Drug Discov; 2013 Mar; 8(3):289-304. PubMed ID: 23317445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Chalcones and Their Derivatives Target the Tumor Microenvironment in Colon Cancer.
    Malla RR; Siragam S; Dadi V; Seetini B
    Crit Rev Immunol; 2022; 42(6):27-39. PubMed ID: 37082949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
    Nehra B; Mathew B; Chawla PA
    Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
    Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
    Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids
    Hisham M; Hassan HA; Gomaa HAM; Youssif BGM; Hayalah AM; Abdel-Aziz M
    Anticancer Agents Med Chem; 2023; 23(17):1932-1943. PubMed ID: 37497685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors.
    George G; Koyiparambath VP; Sukumaran S; Nair AS; Pappachan LK; Al-Sehemi AG; Kim H; Mathew B
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.